Multiple sclerosis affects more women than men. The reasons for this are unknown. Previously, we have shown significant differences in women versus men in inflammatory cytokine responses to the major protein component of myelin, proteolipid protein (PLP), which is thought to be a target in MS patients. Here, using the ELISPOT assay, we examined sex differences in single-cell secretion of Th1 and Th2 cytokines from freshly isolated PBMC between relapsing remitting (RR) MS patients and healthy individuals. Cells were stimulated with MS-associated antigens including proteolipid protein (PLP), myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG), and non-disease related antigens. IFNγ and IL5; (3) by defining the patient population as early, untreated RRMS patients to avoid confounding factors, such as different disease stages/disability and immunomodulatory therapy; and (4) by showing HLA type does not appear to underlie the gender differences. These findings may explain increased susceptibility to MS in women and could contribute to the differences in disease severity between men and women.
Introduction
Many autoimmune diseases are more frequent in women than men, including multiple sclerosis, rheumatoid arthritis, Grave's disease, systemic lupus erythematosus, myasthenia gravis, Sjogren's syndrome and Hashimotos thyroiditis. The reasons for a sex bias in MS and other autoimmune diseases are poorly understood but may include sex-related differences in immune responsiveness, sex steroid or hormonal effects, and sex-linked genetic factors (Whitacre et al., 1999) .
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